Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline
OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized anima...
Gespeichert in:
Veröffentlicht in: | Critical care medicine 2005-01, Vol.33 (1), p.203-208 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 208 |
---|---|
container_issue | 1 |
container_start_page | 203 |
container_title | Critical care medicine |
container_volume | 33 |
creator | Toung, Thomas J. K Chang, Yi Lin, Jonathan Bhardwaj, Anish |
description | OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized animal model of large ischemic stroke, we tested the hypotheses that lung water increases following cerebral ischemia and determined the effects of osmotherapy with hypertonic saline and mannitol on total lung water, as well as on cerebral edema.
DESIGN:Prospective laboratory animal study.
SETTING:Research laboratory in a university teaching hospital.
SUBJECTS:Adult male Wistar rats (300–450 g, n = 103).
INTERVENTIONS:Under controlled conditions of normoxia, normocarbia, and normothermia, spontaneously breathing, halothane-anesthetized (1.0–1.5%) rats were subjected to permanent middle cerebral artery occlusion by the intraluminal occlusion technique.
MEASUREMENTS AND MAIN RESULTS:Cerebral perfusion was monitored by laser-Doppler flowmetry over ipsilateral parietal cortex to ensure adequate vascular occlusion. At 6 hrs following middle cerebral artery occlusion, rats were treated in a blinded randomized fashion with no intravenous fluids (n = 24), a continuous intravenous infusion (0.3 mL/hr) of 0.9% saline (n = 21), 20% mannitol (2 g/Kg) (n = 20), 5% hypertonic saline (n = 20), or 7.5% hypertonic saline (n = 18) as a chloride/acetate mixture (50:50) until the end of the experiment. Brains and lungs were harvested, and tissue water content was estimated by comparing wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 48 hrs postischemia. Sham-operated rats served as controls (n = 20). Serum osmolality was determined at the end of the experiment in all animals. Lung water content was increased significantly in rats subjected to middle cerebral artery occlusion and treated with no intravenous fluids (76.7 ± 0.7%, 317 ± 7 mOsm/L) (mean ± sd) and saline (76.8 ± 1.2%, 311 ± 10 mOsm/L), compared with sham-operated controls (74.5 ± 0.9%, 302 ± 4 mOsm/L). Treatment with 20% mannitol (74.4 ± 1.2%, 352 ± 15 mOsm/L), 5% hypertonic saline (75.6 ± 1.3%, 339 ± 16 mOsm/L), and 7.5% hypertonic saline (74.9 ± 0.7%, 360 ± 23 mOsm/L) significantly attenuated lung water content. Hemispheric brain water content increased both in the ipsilateral ischemic and contralateral hemispheres treated with saline (ipsilateral, 85.1 ± 1.7%; contralateral, 80.7 ± 0.7%), |
doi_str_mv | 10.1097/01.CCM.0000150659.15558.23 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67370748</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67370748</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3920-e39777a609f9697692be1214ebf38d870f2367efb8db1ebc99667c95a5e5f5973</originalsourceid><addsrcrecordid>eNpFkE1vEzEQQC0EoqHwF5CFBLcN4_XaXveGokIrteICZ8vrjMlSxw72rtL-e5wPKb5YM_NmRvMI-cRgyUCrr8CWq9XjEupjAqTQSyaE6Jctf0UWTHBooNX8NVkAaGh4p_kVeVfK34p3QvG35IoJ2XVSwYKM99FltAULHSMNc_xDbVzTIdsa7u2EmfoUQtqPtYLPO8zjFuNkAy1TTk94Q2-9RzfR5OnWxjhOKRwnbF4qO6U4OlpsGCO-J2-8DQU_nP9r8vv77a_VXfPw88f96ttD47huoUGulVJWgvZaaiV1OyBrWYeD5_26V-BbLhX6oV8PDAentZTKaWEFCi-04tfky2nuLqd_M5bJbMfiMAQbMc3FSMUVqK6v4M0JdDmVktGbXT3O5hfDwBxEG2CmijYX0eYo2rS8Nn88b5mHLa4vrWezFfh8BmxxNvhsoxvLhZMdKA0Hrjtx-xSq7fIU5j1ms0Ebps1xNW872bQAAliNmkMG-H-u35bt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67370748</pqid></control><display><type>article</type><title>Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Toung, Thomas J. K ; Chang, Yi ; Lin, Jonathan ; Bhardwaj, Anish</creator><creatorcontrib>Toung, Thomas J. K ; Chang, Yi ; Lin, Jonathan ; Bhardwaj, Anish</creatorcontrib><description>OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized animal model of large ischemic stroke, we tested the hypotheses that lung water increases following cerebral ischemia and determined the effects of osmotherapy with hypertonic saline and mannitol on total lung water, as well as on cerebral edema.
DESIGN:Prospective laboratory animal study.
SETTING:Research laboratory in a university teaching hospital.
SUBJECTS:Adult male Wistar rats (300–450 g, n = 103).
INTERVENTIONS:Under controlled conditions of normoxia, normocarbia, and normothermia, spontaneously breathing, halothane-anesthetized (1.0–1.5%) rats were subjected to permanent middle cerebral artery occlusion by the intraluminal occlusion technique.
MEASUREMENTS AND MAIN RESULTS:Cerebral perfusion was monitored by laser-Doppler flowmetry over ipsilateral parietal cortex to ensure adequate vascular occlusion. At 6 hrs following middle cerebral artery occlusion, rats were treated in a blinded randomized fashion with no intravenous fluids (n = 24), a continuous intravenous infusion (0.3 mL/hr) of 0.9% saline (n = 21), 20% mannitol (2 g/Kg) (n = 20), 5% hypertonic saline (n = 20), or 7.5% hypertonic saline (n = 18) as a chloride/acetate mixture (50:50) until the end of the experiment. Brains and lungs were harvested, and tissue water content was estimated by comparing wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 48 hrs postischemia. Sham-operated rats served as controls (n = 20). Serum osmolality was determined at the end of the experiment in all animals. Lung water content was increased significantly in rats subjected to middle cerebral artery occlusion and treated with no intravenous fluids (76.7 ± 0.7%, 317 ± 7 mOsm/L) (mean ± sd) and saline (76.8 ± 1.2%, 311 ± 10 mOsm/L), compared with sham-operated controls (74.5 ± 0.9%, 302 ± 4 mOsm/L). Treatment with 20% mannitol (74.4 ± 1.2%, 352 ± 15 mOsm/L), 5% hypertonic saline (75.6 ± 1.3%, 339 ± 16 mOsm/L), and 7.5% hypertonic saline (74.9 ± 0.7%, 360 ± 23 mOsm/L) significantly attenuated lung water content. Hemispheric brain water content increased both in the ipsilateral ischemic and contralateral hemispheres treated with saline (ipsilateral, 85.1 ± 1.7%; contralateral, 80.7 ± 0.7%), compared with sham-operated controls (ipsilateral, 79.6 ± 0.9%; contralateral, 79.5 ± 0.9%), as well as in rats that received no fluids (ipsilateral, 84.6 ± 1.8%; contralateral, 80.4 ± 0.9%). Treatment with 5% hypertonic saline (ipsilateral, 83.8 ± 1.0%; contralateral, 79.7 ± 0.6%) and 7.5% hypertonic saline (ipsilateral, 82.3 ± 1.3%; contralateral, 78.6 ± 0.7%) resulted in attenuation of stroke-associated increases in brain water content to a greater extent than mannitol (ipsilateral, 83.6 ± 1.6%; contralateral, 79.1 ± 1.0%).
CONCLUSIONS:In a well-characterized animal model of large ischemic stroke, total lung water content increases, which is likely neurogenic in origin. Attenuation of stroke-associated increases in lung and brain water content with continuous infusion of hypertonic saline may have therapeutic implication in the treatment of cerebral and pulmonary edema following ischemic stroke.</description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/01.CCM.0000150659.15558.23</identifier><identifier>PMID: 15644670</identifier><identifier>CODEN: CCMDC7</identifier><language>eng</language><publisher>Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams & Wilkins</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Brain Edema - physiopathology ; Dominance, Cerebral - physiology ; Extravascular Lung Water - drug effects ; Extravascular Lung Water - metabolism ; Infarction, Middle Cerebral Artery - physiopathology ; Intensive care medicine ; Male ; Mannitol - pharmacology ; Medical sciences ; Neurology ; Pharmacology. Drug treatments ; Pulmonary Edema - physiopathology ; Rats ; Rats, Wistar ; Saline Solution, Hypertonic - pharmacology ; Vascular diseases and vascular malformations of the nervous system ; Water-Electrolyte Balance - drug effects</subject><ispartof>Critical care medicine, 2005-01, Vol.33 (1), p.203-208</ispartof><rights>2005 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3920-e39777a609f9697692be1214ebf38d870f2367efb8db1ebc99667c95a5e5f5973</citedby><cites>FETCH-LOGICAL-c3920-e39777a609f9697692be1214ebf38d870f2367efb8db1ebc99667c95a5e5f5973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16407900$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15644670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toung, Thomas J. K</creatorcontrib><creatorcontrib>Chang, Yi</creatorcontrib><creatorcontrib>Lin, Jonathan</creatorcontrib><creatorcontrib>Bhardwaj, Anish</creatorcontrib><title>Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized animal model of large ischemic stroke, we tested the hypotheses that lung water increases following cerebral ischemia and determined the effects of osmotherapy with hypertonic saline and mannitol on total lung water, as well as on cerebral edema.
DESIGN:Prospective laboratory animal study.
SETTING:Research laboratory in a university teaching hospital.
SUBJECTS:Adult male Wistar rats (300–450 g, n = 103).
INTERVENTIONS:Under controlled conditions of normoxia, normocarbia, and normothermia, spontaneously breathing, halothane-anesthetized (1.0–1.5%) rats were subjected to permanent middle cerebral artery occlusion by the intraluminal occlusion technique.
MEASUREMENTS AND MAIN RESULTS:Cerebral perfusion was monitored by laser-Doppler flowmetry over ipsilateral parietal cortex to ensure adequate vascular occlusion. At 6 hrs following middle cerebral artery occlusion, rats were treated in a blinded randomized fashion with no intravenous fluids (n = 24), a continuous intravenous infusion (0.3 mL/hr) of 0.9% saline (n = 21), 20% mannitol (2 g/Kg) (n = 20), 5% hypertonic saline (n = 20), or 7.5% hypertonic saline (n = 18) as a chloride/acetate mixture (50:50) until the end of the experiment. Brains and lungs were harvested, and tissue water content was estimated by comparing wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 48 hrs postischemia. Sham-operated rats served as controls (n = 20). Serum osmolality was determined at the end of the experiment in all animals. Lung water content was increased significantly in rats subjected to middle cerebral artery occlusion and treated with no intravenous fluids (76.7 ± 0.7%, 317 ± 7 mOsm/L) (mean ± sd) and saline (76.8 ± 1.2%, 311 ± 10 mOsm/L), compared with sham-operated controls (74.5 ± 0.9%, 302 ± 4 mOsm/L). Treatment with 20% mannitol (74.4 ± 1.2%, 352 ± 15 mOsm/L), 5% hypertonic saline (75.6 ± 1.3%, 339 ± 16 mOsm/L), and 7.5% hypertonic saline (74.9 ± 0.7%, 360 ± 23 mOsm/L) significantly attenuated lung water content. Hemispheric brain water content increased both in the ipsilateral ischemic and contralateral hemispheres treated with saline (ipsilateral, 85.1 ± 1.7%; contralateral, 80.7 ± 0.7%), compared with sham-operated controls (ipsilateral, 79.6 ± 0.9%; contralateral, 79.5 ± 0.9%), as well as in rats that received no fluids (ipsilateral, 84.6 ± 1.8%; contralateral, 80.4 ± 0.9%). Treatment with 5% hypertonic saline (ipsilateral, 83.8 ± 1.0%; contralateral, 79.7 ± 0.6%) and 7.5% hypertonic saline (ipsilateral, 82.3 ± 1.3%; contralateral, 78.6 ± 0.7%) resulted in attenuation of stroke-associated increases in brain water content to a greater extent than mannitol (ipsilateral, 83.6 ± 1.6%; contralateral, 79.1 ± 1.0%).
CONCLUSIONS:In a well-characterized animal model of large ischemic stroke, total lung water content increases, which is likely neurogenic in origin. Attenuation of stroke-associated increases in lung and brain water content with continuous infusion of hypertonic saline may have therapeutic implication in the treatment of cerebral and pulmonary edema following ischemic stroke.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Brain Edema - physiopathology</subject><subject>Dominance, Cerebral - physiology</subject><subject>Extravascular Lung Water - drug effects</subject><subject>Extravascular Lung Water - metabolism</subject><subject>Infarction, Middle Cerebral Artery - physiopathology</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Mannitol - pharmacology</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary Edema - physiopathology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Saline Solution, Hypertonic - pharmacology</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><subject>Water-Electrolyte Balance - drug effects</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1vEzEQQC0EoqHwF5CFBLcN4_XaXveGokIrteICZ8vrjMlSxw72rtL-e5wPKb5YM_NmRvMI-cRgyUCrr8CWq9XjEupjAqTQSyaE6Jctf0UWTHBooNX8NVkAaGh4p_kVeVfK34p3QvG35IoJ2XVSwYKM99FltAULHSMNc_xDbVzTIdsa7u2EmfoUQtqPtYLPO8zjFuNkAy1TTk94Q2-9RzfR5OnWxjhOKRwnbF4qO6U4OlpsGCO-J2-8DQU_nP9r8vv77a_VXfPw88f96ttD47huoUGulVJWgvZaaiV1OyBrWYeD5_26V-BbLhX6oV8PDAentZTKaWEFCi-04tfky2nuLqd_M5bJbMfiMAQbMc3FSMUVqK6v4M0JdDmVktGbXT3O5hfDwBxEG2CmijYX0eYo2rS8Nn88b5mHLa4vrWezFfh8BmxxNvhsoxvLhZMdKA0Hrjtx-xSq7fIU5j1ms0Ebps1xNW872bQAAliNmkMG-H-u35bt</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Toung, Thomas J. K</creator><creator>Chang, Yi</creator><creator>Lin, Jonathan</creator><creator>Bhardwaj, Anish</creator><general>by the Society of Critical Care Medicine and Lippincott Williams & Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200501</creationdate><title>Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline</title><author>Toung, Thomas J. K ; Chang, Yi ; Lin, Jonathan ; Bhardwaj, Anish</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3920-e39777a609f9697692be1214ebf38d870f2367efb8db1ebc99667c95a5e5f5973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Brain Edema - physiopathology</topic><topic>Dominance, Cerebral - physiology</topic><topic>Extravascular Lung Water - drug effects</topic><topic>Extravascular Lung Water - metabolism</topic><topic>Infarction, Middle Cerebral Artery - physiopathology</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Mannitol - pharmacology</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary Edema - physiopathology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Saline Solution, Hypertonic - pharmacology</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><topic>Water-Electrolyte Balance - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toung, Thomas J. K</creatorcontrib><creatorcontrib>Chang, Yi</creatorcontrib><creatorcontrib>Lin, Jonathan</creatorcontrib><creatorcontrib>Bhardwaj, Anish</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toung, Thomas J. K</au><au>Chang, Yi</au><au>Lin, Jonathan</au><au>Bhardwaj, Anish</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>2005-01</date><risdate>2005</risdate><volume>33</volume><issue>1</issue><spage>203</spage><epage>208</epage><pages>203-208</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><coden>CCMDC7</coden><abstract>OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized animal model of large ischemic stroke, we tested the hypotheses that lung water increases following cerebral ischemia and determined the effects of osmotherapy with hypertonic saline and mannitol on total lung water, as well as on cerebral edema.
DESIGN:Prospective laboratory animal study.
SETTING:Research laboratory in a university teaching hospital.
SUBJECTS:Adult male Wistar rats (300–450 g, n = 103).
INTERVENTIONS:Under controlled conditions of normoxia, normocarbia, and normothermia, spontaneously breathing, halothane-anesthetized (1.0–1.5%) rats were subjected to permanent middle cerebral artery occlusion by the intraluminal occlusion technique.
MEASUREMENTS AND MAIN RESULTS:Cerebral perfusion was monitored by laser-Doppler flowmetry over ipsilateral parietal cortex to ensure adequate vascular occlusion. At 6 hrs following middle cerebral artery occlusion, rats were treated in a blinded randomized fashion with no intravenous fluids (n = 24), a continuous intravenous infusion (0.3 mL/hr) of 0.9% saline (n = 21), 20% mannitol (2 g/Kg) (n = 20), 5% hypertonic saline (n = 20), or 7.5% hypertonic saline (n = 18) as a chloride/acetate mixture (50:50) until the end of the experiment. Brains and lungs were harvested, and tissue water content was estimated by comparing wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 48 hrs postischemia. Sham-operated rats served as controls (n = 20). Serum osmolality was determined at the end of the experiment in all animals. Lung water content was increased significantly in rats subjected to middle cerebral artery occlusion and treated with no intravenous fluids (76.7 ± 0.7%, 317 ± 7 mOsm/L) (mean ± sd) and saline (76.8 ± 1.2%, 311 ± 10 mOsm/L), compared with sham-operated controls (74.5 ± 0.9%, 302 ± 4 mOsm/L). Treatment with 20% mannitol (74.4 ± 1.2%, 352 ± 15 mOsm/L), 5% hypertonic saline (75.6 ± 1.3%, 339 ± 16 mOsm/L), and 7.5% hypertonic saline (74.9 ± 0.7%, 360 ± 23 mOsm/L) significantly attenuated lung water content. Hemispheric brain water content increased both in the ipsilateral ischemic and contralateral hemispheres treated with saline (ipsilateral, 85.1 ± 1.7%; contralateral, 80.7 ± 0.7%), compared with sham-operated controls (ipsilateral, 79.6 ± 0.9%; contralateral, 79.5 ± 0.9%), as well as in rats that received no fluids (ipsilateral, 84.6 ± 1.8%; contralateral, 80.4 ± 0.9%). Treatment with 5% hypertonic saline (ipsilateral, 83.8 ± 1.0%; contralateral, 79.7 ± 0.6%) and 7.5% hypertonic saline (ipsilateral, 82.3 ± 1.3%; contralateral, 78.6 ± 0.7%) resulted in attenuation of stroke-associated increases in brain water content to a greater extent than mannitol (ipsilateral, 83.6 ± 1.6%; contralateral, 79.1 ± 1.0%).
CONCLUSIONS:In a well-characterized animal model of large ischemic stroke, total lung water content increases, which is likely neurogenic in origin. Attenuation of stroke-associated increases in lung and brain water content with continuous infusion of hypertonic saline may have therapeutic implication in the treatment of cerebral and pulmonary edema following ischemic stroke.</abstract><cop>Hagerstown, MD</cop><pub>by the Society of Critical Care Medicine and Lippincott Williams & Wilkins</pub><pmid>15644670</pmid><doi>10.1097/01.CCM.0000150659.15558.23</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-3493 |
ispartof | Critical care medicine, 2005-01, Vol.33 (1), p.203-208 |
issn | 0090-3493 1530-0293 |
language | eng |
recordid | cdi_proquest_miscellaneous_67370748 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Brain Edema - physiopathology Dominance, Cerebral - physiology Extravascular Lung Water - drug effects Extravascular Lung Water - metabolism Infarction, Middle Cerebral Artery - physiopathology Intensive care medicine Male Mannitol - pharmacology Medical sciences Neurology Pharmacology. Drug treatments Pulmonary Edema - physiopathology Rats Rats, Wistar Saline Solution, Hypertonic - pharmacology Vascular diseases and vascular malformations of the nervous system Water-Electrolyte Balance - drug effects |
title | Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A57%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increases%20in%20lung%20and%20brain%20water%20following%20experimental%20stroke:%20Effect%20of%20mannitol%20and%20hypertonic%20saline&rft.jtitle=Critical%20care%20medicine&rft.au=Toung,%20Thomas%20J.%20K&rft.date=2005-01&rft.volume=33&rft.issue=1&rft.spage=203&rft.epage=208&rft.pages=203-208&rft.issn=0090-3493&rft.eissn=1530-0293&rft.coden=CCMDC7&rft_id=info:doi/10.1097/01.CCM.0000150659.15558.23&rft_dat=%3Cproquest_cross%3E67370748%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67370748&rft_id=info:pmid/15644670&rfr_iscdi=true |